Physicians Research Options LLC

1. Abbott Laboratories $917,507 67 payments
2. Organon LLC $237,513 76 payments
3. AbbVie, Inc. $199,248 45 payments
4. Sumitomo Pharma America, Inc. $106,019 63 payments
5. Pfizer Inc. $80,597 13 payments
6. Allergan Inc. $76,704 10 payments
7. Mylan Technologies Inc. $62,580 8 payments
8. Mylan Inc. $49,983 8 payments
9. Bayer HealthCare Pharmaceuticals Inc. $41,992 34 payments
10. Scilex Pharmaceuticals Inc. $29,581 6 payments

1. Alinity m HR HPV Specimen Collection Study from Women Undergoing Routine Cervical cancer Screening $379,592 23 payments
2. Alinity m HR HPV Specimen Collection Study from Women Referred to Colposcopy $256,272 22 payments
3. M16-100 $111,340 26 payments
4. A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids Or Endometriosis $106,019 63 payments
5. Alinity m HR HPV Self-Collect Study (CE) Protocol for Specimen Collection from Subjects Undergoing Routine Cervical Cancer Screening $77,689 13 payments
6. Testosterone Replacement therapy for Assessment of long-term Vascular Events and efficacy ResponSE in hypogonadal men (TRAVERSE) Study $71,159 11 payments
7. A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Cenicriviroc for the Treatment of Liver Fibrosis in Adult Subjects With Nonalcoholic Steatohepatitis. $69,704 9 payments
8. A Phase 3 Randomized Double Blind Placebo and Activecontrolled Multicenter Parallelgroup Study of the Analgesic Efficacy and Safety of Tanezumab in Adult Subjects With Chronic Low Back Pain $65,822 10 payments
9. Og-8175A-023 $64,643 24 payments
10. Phase 3, Multicenter, Open-Label, Single Arm Study of Mr-100A-01 in Women of Childbearing Potential to Evaluate Contraceptive Efficacy and Safety $62,580 8 payments

1. Patient care $267,094 82 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.